Latest News

  • The Why And How Of Moving STD Testing Closer To the Point Of Care

    Diagnostics World News Infectious disease diagnosis has been shifting from culture-based methods and immunoassays to molecular diagnostic testing, and more of the work is happening at the point of care (POC) rather than a centralized lab.

    Sep 20, 2021
  • Diagnosing An Outbreak: Advancing Diagnostic Technology For Infectious Diseases

    Diagnostics World News | When a disease outbreak occurs, the first stage of the response is detection. During the initial stages of Zika and COVID-19 outbreaks, The World Health Organization (WHO) identified effective diagnostic testing as one of the key factors in monitoring and managing the spread of the disease.

    Sep 16, 2021
  • Lab Chip Aims To Amp Up Pathogen Detection At The Point Of Care

    Diagnostics World News | Many of the biological assays currently done in clinical labs could be performed at the point of care (POC), thanks to microfluidic lab-on-chip devices for the rapid detection of pathogens, which might also be useful for pathogen identification, antibody susceptibility testing, or to measure host response based on cell count, proteins, or other biological entities.

    Sep 15, 2021
  • Street Medicine Program Bringing Point-Of-Care Testing To The Homeless

    Diagnostics World News | A street medicine program is employing point-of-care testing (POCT) to mitigate the heightened risk of chronic diseases and death among the homeless in Los Angeles. Testing for glucose, hemoglobin, and hemoglobin A1c are currently available, but the menu will expand to include urine-based assays, she says.

    Sep 13, 2021
  • Metabolomics And Machine Learning Create ‘Signatures’ Of Viral Infections

    Diagnostics World News | Over 18,000 different metabolites have been identified in humans that could potentially be altered by a respiratory virus infection, according to Benjamin Pinsky, M.D., Ph.D., medical director of the clinical virology laboratory at Stanford Health Care, speaking on advances in metabolomics at last week’s Next Generation Dx Summit. The changes can be detected by the coupling of liquid chromatography with mass spectrometry to produce host metabolic signatures.

    Sep 9, 2021
  • Testing Caveats Learned (And Relearned) During the Pandemic

    Diagnostic World News | A long list of diagnostic adages have held true during the COVID-19 pandemic: a proactive and organized scientific approach yields excellent results, serology is not useful for detecting respiratory viruses, not all nucleic acid amplification tests perform equivalently, different specimens yield different results, pooling will miss low-level positives, RT-PCR is more sensitive than antigen tests, pretest probability is directly related to post-test-probability, and errors occur when implementations are rushed.

    Sep 8, 2021
  • The Lowdown On Rapid Antigen Testing For COVID-19

    Diagnostics World News | The proper role of COVID-19 diagnostics, and especially rapid antigen tests, was the subject of a wide-ranging and mathematically oriented keynote presentation by Gerald Kost, M.D., Ph.D., director of the Point-of-Care Testing Center for Teaching and Research at the University of California, Davis, at the recent Next Generation Dx Summit. During his 30-minute talk, he took both the U.S. Food and Drug Administration (FDA) and the Cambodian government to task on their decision-making during the pandemic.

    Sep 7, 2021
  • Follow the Money: Alzheimer’s Disease Research, Wearables for Metabolic Health Disorders

    Diagnostics World News | HealthTech SPAC funding, wearable fitness program for metabolic health disorders, multiple academic grants for dementia research and other causal connections in the brain, and more.

    Sep 3, 2021
  • Updated EUAs for COVID Variants, Kidney Disease Diagnostics Could Save Millions, New Products

    Diagnostics World News | Budget analysis suggests substantial savings for early kidney disease diagnosis, Harvard-Israel diagnostic partnership, AI for detecting cancer in the GI tract, and update EUAs for Thermo Fisher and Spectrum Solutions. Plus new products from Smart Meter, Dosis, Rhinomed, and more.

    Sep 1, 2021
  • Quest Diagnostics Takes Lead On Making Healthcare More Consumer-Centric

    Diagnostics World News | The M.O. of healthcare is to accommodate providers rather than individuals seeking care and that runs counter to the industry’s “triple aim” of improving the health of populations, enhancing the experience of care, and lowering per capita costs, according to Jay G. Wohlgemuth, M.D., chief medical officer for Quest Diagnostics Nichols Institute. The pandemic has spotlighted some of these well-known failings but also provided some lessons on how to operate in a more consumer-centric way.

    Aug 31, 2021
  • Clinical Labs, In The Eye Of The Storm, Start Getting Creative

    Diagnostics World News | The pandemic ushered in a climate of uncertainty and high-stakes decision-making that has inspired a lot of ingenuity and innovation in clinical laboratories, according to Esther Babady, Ph.D., medical director of the clinical microbiology service at Memorial Sloan Kettering (MSK) Cancer Center, speaking earlier this week at the Next Generation Dx Summit.

    Aug 30, 2021
  • How to Address the Silent, Looming Threat of Antibiotic-Resistant Sexually Transmitted Infections

    Diagnostics World News | Sexually transmitted infections are at an all-time high, affecting one in five Americans. We may be entering a critical era for sexually transmitted infections (STIs) as antibiotic-resistant infections have developed the potential to affect virtually all humans, making antibiotic resistance “one of the world’s most urgent public health problems,” according to the U.S. Centers for Disease Control and Prevention (CDC).

    Aug 27, 2021
  • Practical Tips On Implementing Point-Of-Care Testing In The Hospital Setting

    Diagnostics World News | When implementing a point-of-care testing (POCT) program in an organization with thousands of users across multiple sites, it helps to have a multidisciplinary committee to provide needed oversight, match the scope of testing to clinical need, and keep the lines of communication open. The hospital IT department is an “often overlooked” friend in the process.

    Aug 26, 2021
  • ‘Unprecedented’ Diagnostics Platform Could Slash Healthcare Costs Globally

    Diagnostics World News | Connected diagnostics and care automation could remove one trillion dollars in annual global healthcare spending, or roughly 10% of the outlay in 2022, according to Ken Mayer, founder and CEO of Safe Health Systems, who presented yesterday at the Next Generation Dx Summit. The enabler may well be a digital health and diagnostic platform the company operates in partnership with the Mayo Clinic.

    Aug 25, 2021
  • Plaque-Seeking Nanoparticles Could Aid In Detecting And Treating Heart Attacks

    Diagnostics World News | Thanks to photoacoustics, a blend of modern-day ultrasound machines and lasers, physicians in the next decade could be using a routine imaging test to “hear” the sound signal of a future heart attack. As envisioned, photoacoustic imaging would likely serve as a complement to intravascular ultrasound (IVUS) or standard ultrasound by reporting on the whereabouts and inflammatory status of atherosclerotic plaque.

    Aug 24, 2021
  • Next-Generation Sequencing Unlocks a New Era in Precision Medicine

    Diagnostics World News | For the benefit of laboratory and healthcare professionals, the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) published joint guidelines in 2015 aimed at standardizing terminology and the classification of sequence variants uncovered through genetic testing. Understandably, in the several years since then, there have been tremendous advances in this field of molecular diagnostics such as next-generation sequencing (NGS) technologies unlocking new opportunities to understand an individual’s unique genetic makeup. Armed with these insights, healthcare providers can personalize therapeutic options for their patients with genetic diseases, helping to manage or treat them altogether.

    Aug 20, 2021
  • Multimodal Nanosensor Can Both Detect And Locate Cancerous Tumors

    Diagnostic World News | Researchers at Massachusetts Institute of Technology have developed a urine-based molecular assay that can both reveal the presence of cancerous proteins and pinpoint a tumor’s location. The double-duty diagnostic nanosensor could one day be of clinical value in evaluating treatment response and long-term monitoring of tumor recurrence.

    Aug 17, 2021
  • FDA Working on New Way to Approve AI and ML Software in Medical Devices

    Diagnostics World News | The US Food and Drug Administration (FDA) in February issued an AI and Machine Learning Software as a Medical Device Action Plan, outlining the way forward for manufacturers seeking the agency’s approval for their innovative medical devices incorporating AI.

    Aug 12, 2021
  • Efforts Emerge to Fight Off Future Pandemics

    Diagnostics World News | As the coronavirus pandemic continues, new initiatives are emerging to help fend off future pandemics including the Pandemic Sciences Centre at the University of Oxford and the Centers for Research in Emerging Infectious Diseases, a global network investigating how and where viruses and other pathogens emerge from wildlife settings.

    Aug 9, 2021
  • Follow the Money: Liquid Biopsy, AI-Guided Therapies

    Diagnostics World News | InterVenn closes a series C for liquid biopsy assay for immune checkpoint inhibitor response prediction, Strata advances personalized minimal residual disease (MRD) assays, Lumos Diagnostics in Australia goes public, and more.

    Aug 5, 2021